Riggsbee Richard Bryan — SEC Form 4 filings

SEC reporting owner CIK 1621899. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-14.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-01-31 to 2026-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CareDx, Inc. (CDNA)Director48
NEOGEN CORP (NEOG)CFO24
MYRIAD GENETICS INC (MYGN)Chief Financial Officer1

Form 4 filings — Riggsbee Richard Bryan

FiledFormIssuerReported transactionsSource
2026-08-144NEOGEN CORP (NEOG)Grant/award (A): 51,502 @ $11.65 · Grant/award (A): 261,702 (derivative) @ $0EDGAR
2026-06-164CareDx, Inc. (CDNA)Grant/award (A): 9,795 @ $0EDGAR
2025-11-054NEOGEN CORP (NEOG)Grant/award (A): 178,855 @ $6.29 · Grant/award (A): 459,713 (derivative) @ $0EDGAR
2025-06-174CareDx, Inc. (CDNA)Grant/award (A): 12,103 @ $0EDGAR
2024-06-204/ACareDx, Inc. (CDNA)Grant/award (A): 9,760 (derivative) @ $0 · Grant/award (A): 16,048 (derivative) @ $0EDGAR
2024-06-174CareDx, Inc. (CDNA)Grant/award (A): 6,844 @ $0 · Grant/award (A): 10,570 @ $0 · Grant/award (A): 9,760 (derivative) @ $0 · Grant/award (A): 16,048 (derivative) @ $0EDGAR
2024-01-314MYRIAD GENETICS INC (MYGN)Holdings only — no transactions reportedEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1621899 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →